• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Drug Safety Oversight Board Meeting: December 18, 2008 Public Summary

Public Summary

  • The Executive Director updated the Board on Public Health Advisories (PHAs), Early Communications about Ongoing Safety Reviews (ECs) and Information for Healthcare Professionals (HCP) sheets posted since the October 16, 2008 meeting (all available at: Index to Drug-Specific Information) and those in development.
  • The Drug Safety Oversight Board discussed its role in how FDA should communicate drug safety information and its future role in improving communications (e.g., a more proactive communication strategy). Included were discussions of how the various Board functions relate to the new drug safety initiatives at FDA and how a partnership with the Board could facilitate these initiatives.